Latest filing published 12 Aug 2026 for Immunome Inc., €1.4M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Isaac Barchas, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Immunome Inc. and TMC the metals Co Inc. We count 13 filings; the first trade dates from 9 September 2021 and the latest from 12 August 2026.
Sales make up the whole of the open-market record (12 sales, €11.9M). The totals exclude 3 filings filed without an amount. Besides market trades, the filings include 1 option exercise. In 2026 alone, the filings show no purchases and 10 sales.
The newest entry dates from 12 August 2026: an open-market sale of €228k, in Immunome Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations